[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$mrsn
Mersana Therapeutics' Napi2b treatment shows strong performance, exceeding competitors and influencing breast cancer treatment discussions. Recent social posts highlight significant gains and comparisons with other biotech stocks.
About $mrsn
Mersana Therapeutics is a biopharmaceutical company focused on developing novel cancer treatments.
Insights
- $mrsn posts created is up 4268.18% from the previous month.
Engagements: XX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXXX +3,713%
X Months: XXXXXXX +5.50%
X Year: XXXXXXXXX +17%
1-Year High: XXXXXXX on 2025-11-13
1-Year Low: X on 2025-09-25
Engagements by network (24h): X: XX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXXXX +2,911%
X Months: XXXXX +325%
X Year: XXXXX +203%
1-Year High: XXX on 2025-11-14
1-Year Low: X on 2025-09-14
Mentions by network (24h): X: XX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $mrsn in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX +3,205%
X Months: XXXXX +617%
X Year: XXXXX +542%
1-Year High: XXX on 2025-11-14
1-Year Low: X on 2025-04-21
The most influential creators that mention $mrsn in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @thegunnerab | X | XXXXX | X | XX |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XX% -X%
X Month: XXX% +50%
X Months: XXX% no change
X Year: XXX% +23%
1-Year High: XXX% on 2024-12-30
1-Year Low: XX% on 2025-05-19
Most Supportive Themes:
- Positive Treatment Results: (40%) MRSN's Napi2b treatment is demonstrating strong performance, exceeding that of competitors.
- Evolving Breast Cancer Treatment Discussions: (30%) Recent ESMO data is influencing the conversation around ER+ breast cancer treatments.
Most Critical Themes:
- Competitor Performance: (30%) MRSN's treatment is being compared against competitors like MRSN, RHHBY, and ZYME.
Top $mrsn Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@given2tweet I had Trius and Tobira (both zeros) before 2025 but picked up $VERV $MTSR $ETNB this year. What's your take on the $DAWN $MRSN one A lot of mini payouts over the full development cycle"
X Link @SnupSnus 2025-12-07T01:18Z 1735 followers, XX engagements
"$MRSN +203.61% $RUBI +34.47% $DDS +19.13% Get top stock buy signals and trading guides ✅Topics include value stocks dividend picks entry/exit signals and more. #StockAlerts #TradingSignals #DailyProfits #MarketInsights"
X Link @TT62416 2025-12-06T20:50Z 1539 followers, XX engagements
"$MRSN $TNMG $IDN 🔍 Tap into free professional market analysis and proven strategies. 👥 Network with a global coalition of savvy investors and take your portfolio to the next level"
X Link @Reid_Hoffman01 2025-12-02T20:55Z X followers, XXX engagements
"I scan over 3000 targets daily to filter out genuine investment opportunities for you. Add me on WhatsApp 👇 and send "S" Unlock a curated investment portfolio for free 🎁 $CTM $PBR $LDDFD $BAER $MRSN"
X Link @ScottThoma39434 2025-11-29T00:45Z X followers, XX engagements